Sjogren's Syndrome
Sjogren's syndrome is an autoimmune disorder that primarily affects the body's moisture-producing glands, leading to symptoms such as dry mouth, dry eyes, and fatigue.
Sjögren’s Syndrome: Deucravacitinib Study
We are testing a new medication, deucravacitinib, for adults with active Sjögren’s Syndrome to see if it improves symptoms better than a placebo. The study also looks at the safety and tolerability of this treatment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have Sjogren's syndrome (SjS)?
- Do you have any other autoimmune diseases like rheumatoid arthritis or lupus?
- Have you had severe complications from Sjogren's syndrome, such as vasculitis or lymphoma?
- Have you ever taken a medication called deucravacitinib or any other TYK2 inhibitor?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Graz
Department of Rheumatology and Immunology
Graz, Austria
Universitair Ziekenhuis Gent
Rheumatology
Ledeberg, Belgium
University Multiprofile Hospital For Active Treatment Kaspela EOOD
Clinic of Rheumatology
Plovdiv, Bulgaria
Sponsor: Bristol-Myers Squibb Services Unlimited Company
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.